Product
G/C
1 clinical trial
4 indications
Indication
CancerIndication
Colorectal CancerIndication
Lung CancerIndication
Bile Duct CancerClinical trial
A Phase 1 / 2 Study of CAN04, a Fully Humanized Monoclonal Antibody Against IL1RAP, in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid TumoursStatus: Completed, Estimated PCD: 2023-06-23